Labcorp Holdings Inc.
Labcorp Holdings
LH · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $14B
- Assets
- $18.4B
- SEC filing
- DEF 14A
- Filed
- April 10, 2026
Executive Compensation
Compensation reported for Labcorp Holdings’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Adam H. Schechter
President And Chief Executive Officer
$18.3M
Reported total
- Salary
- $1,435,000
- Stock awards
- $11,400,463
- Incentives
- $2,062,095
- Option awards
- $2,754,582
- Other
- $687,773
Julia A. Wang
Executive Vice President And Chief Financial Officer
$5M
Reported total
- Salary
- $737,500
- Stock awards
- $2,681,239
- Incentives
- $906,755
- Option awards
- $649,116
- Other
- $40,259
Mark S. Schroeder
Former Executive Vice President And President, Diagnostics
$4.8M
Reported total
- Salary
- $748,461
- Stock awards
- $2,514,961
- Incentives
- $727,399
- Option awards
- $607,506
- Other
- $188,830
Brian J. Caveney
Executive Vice President And President, Early
$4.4M
Reported total
- Salary
- $748,461
- Stock awards
- $2,304,466
- Incentives
- $719,907
- Option awards
- $557,574
- Other
- $25,515
Megan D. Bailey
Executive Vice President And President, Central Laboratories And International
$2.7M
Reported total
- Salary
- $568,500
- Stock awards
- $1,257,480
- Incentives
- $547,622
- Option awards
- $307,914
- Other
- $34,751
Adam H. Schechter
President And Chief Executive Officer
$18.3M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed April 10, 2026.
- Salary
- $1.4M
- Stock Awards
- $11.4M
- Option Awards
- $2.8M
- Incentives
- $2.1M
- Other
- $688K
Historical Compensation
Adam H. Schechter total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,435,000 | $11,400,463 | $18,339,913 |
| 2024 | $1,416,077 | $12,162,271 | $19,327,354 |
| 2023 | $1,373,692 | $9,071,320 | $15,979,355 |
Named Executive Officers
Adam H. Schechter
President And Chief Executive Officer
Labcorp Holdings · LH
$18.3M
FY 2025 · DEF 14A
Julia A. Wang
Executive Vice President And Chief Financial Officer
Labcorp Holdings · LH
$5M
FY 2025 · DEF 14A
Megan D. Bailey
Executive Vice President And President, Central Laboratories And International
Labcorp Holdings · LH
$2.7M
FY 2025 · DEF 14A
Brian J. Caveney
Executive Vice President And President, Early
Labcorp Holdings · LH
$4.4M
FY 2025 · DEF 14A
Mark S. Schroeder
Former Executive Vice President And President, Diagnostics
Labcorp Holdings · LH
$4.8M
FY 2025 · DEF 14A
Source information
- Company
- Labcorp Holdings Inc.
- Ticker
- LH · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- April 10, 2026
- SEC accession number
- 0001193125-26-150752
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company